Unknown

Dataset Information

0

MTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients.


ABSTRACT:

Background

Aberrant activation of the mammalian Target of Rapamycin (mTOR) pathway has been linked to obesity and endocrine therapy resistance, factors that may contribute to Black-White disparities in breast cancer outcomes. We evaluated associations of race and clinicopathological characteristics with mRNA expression of key mTOR pathway genes in breast tumors.

Methods

Surgical tumor tissue blocks were collected from 367 newly diagnosed breast cancer patients (190 Black and 177 White). Gene expression of AKT1, EIF4EBP1, MTOR, RPS6KB2, and TSC1 were quantified by NanoString nCounter. Differential gene expression was assessed using linear regression on log2-transformed values. Gene expression and DNA methylation data from TCGA were used for validation and investigation of race-related differences.

Results

Compared to White women, Black women had relative under-expression of AKT1 (log2 fold-change = - 0.31, 95% CI - 0.44, - 0.18) and RPS6KB2 (log2 fold-change = - 0.11, 95% CI - 0.19, - 0.03). Higher vs. lower tumor grade was associated with relative over-expression of EIF4EBP1 and RPS6KB2, but with lower expression of TSC1. Compared to luminal tumors, triple-negative tumors had relative under-expression of TSC1 (log2 fold-change = - 0.42, 95% CI - 0.22, - 0.01). The results were similar in the TCGA breast cancer dataset. Post-hoc analyses identified differential CpG methylation within the AKT1 and RPS6KB2 locus between Black and White women.

Conclusions

Over-expression of RPS6KB2 and EIF4EBP1 and under-expression of TSC1 might be indicators of more aggressive breast cancer phenotypes. Differential expression of AKT1 and RPS6KB2 by race warrants further investigation to elucidate their roles in racial disparities of treatment resistance and outcomes between Black and White women with breast cancer.

SUBMITTER: Ilozumba MN 

PROVIDER: S-EPMC9130392 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients.

Ilozumba Mmadili N MN   Yao Song S   Llanos Adana A M AAM   Omilian Angela R AR   Zhang Weizhou W   Datta Susmita S   Hong Chi-Chen CC   Davis Warren W   Khoury Thaer T   Bandera Elisa V EV   Higgins Michael M   Ambrosone Christine B CB   Cheng Ting-Yuan David TD  

Discover oncology 20220524 1


<h4>Background</h4>Aberrant activation of the mammalian Target of Rapamycin (mTOR) pathway has been linked to obesity and endocrine therapy resistance, factors that may contribute to Black-White disparities in breast cancer outcomes. We evaluated associations of race and clinicopathological characteristics with mRNA expression of key mTOR pathway genes in breast tumors.<h4>Methods</h4>Surgical tumor tissue blocks were collected from 367 newly diagnosed breast cancer patients (190 Black and 177 W  ...[more]

Similar Datasets

| S-EPMC5458267 | biostudies-literature
| S-EPMC9617173 | biostudies-literature
| S-EPMC6704027 | biostudies-literature
| S-EPMC3903405 | biostudies-literature
| S-EPMC9882752 | biostudies-literature
| S-EPMC5642508 | biostudies-literature
| S-EPMC9990525 | biostudies-literature
| S-EPMC7896729 | biostudies-literature
| S-EPMC5854524 | biostudies-literature
| S-EPMC10328950 | biostudies-literature